 PDUFA for Pedmark sodium thiosulfate in treating platinum chemotherapy-induced cytotoxicity ear toxicity in children is scheduled on September 23. The company resolved the issues raised in the second CRL within 3 months and announced the NDA acceptance in April this year. 